Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN107,9108,2-1,92
Msft-0,13
Nokia5,8665,921,16
IBM1,10
Mercedes-Benz Group AG57,5857,60,89
PFE0,40
14.02.2026 2:04:00
Indexy online
AD Index online
select
AD Index online
 

  • 26.01.2026 15:00:36
Mochida Pharm (4534.F, Frankfurt)
Závěr k 13.2.2026 Změna (%) Změna (EUR) Objem obchodů (EUR)
20,00 -0,99 -0,20 499
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace:
Popis společnosti
Obecné informace
Název společnostiMochida Pharmaceutical Co Ltd
Ticker4534
Kmenové akcie:Ordinary Shares
RIC4534.T
ISINJP3922800002
Poslední známé roční výsledky31.03.2025
Poslední známé čtvrtletní výsledky31.12.2025
Počet zaměstnanců k 31.03.2025 1 508
Akcie v oběhu k 31.12.2025 35 449 909
MěnaJPY
Kontaktní informace
Ulice1-7, Yotsuya
MěstoSHINJUKU-KU
PSČ160-8515
ZeměJapan
Kontatní osobaKenichi Miyamoto
Funkce kontaktní osobyDirector of Accounting
Telefon81 333 587 211
Fax81333587887
Kontatní telefon810 333 587 211

Business Summary: Mochida Pharmaceutical Co Ltd is a Japan-based company principally engaged in the production and sale of drugs. The Pharmaceutical-related segment is engaged in the manufacture, purchase and sale of pharmaceutical products. The Company also conducts brokerage and management of real estate properties, the maintenance and management of buildings, the agency of personal affairs, accounting and purchasing businesses. The Healthcare segment is involved in the manufacture, purchase and sale of quasi drugs and cosmetic products.
Financial Summary: BRIEF: For the nine months ended 31 December 2025, Mochida Pharmaceutical Co Ltd revenues increased 8% to Y87.49B. Net income applicable to common stockholders increased 13% to Y6.34B. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income benefited from Pharmaceutical segment income increase of 4% to Y7.53B. Dividend per share remained flat at Y40.00.
Odvětvová klasifikace
TRBC2012Pharmaceuticals (NEC)
RBSS2004Pharmaceuticals - Generic & Specialty
MGINDUSTRYBiotechnology & Drugs
MGSECTORHealthcare
NAICSPharmaceutical Preparation Manufacturing
NAICSToilet Preparation Manufacturing
NAICSOffices of Real Estate Agents and Brokers
NAICSAll Other Business Support Services
NAICS2007Pharmaceutical Preparation Mfg
NAICS2007Toilet Preparation Manufacturing
NAICS2007Offices of Real Estate Agents and Brokers
NAICS2007All Other Business Support Services
NAICS1997Pharmaceutical Preparation Manufacturing
NAICS1997Toilet Preparation Manufacturing
NAICS1997Offices of Real Estate Agents and Brokers
NAICS1997All Other Business Support Services
SICPharmaceutical Preparations
SICToilet Preparations
SICReal Estate Agents And Managers
SICBusiness Services, Nec



  • Poslední aktualizace:
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
President, Representative DirectorNaoyuki Mochida67
Senior Managing Director, Senior Managing Executive Officer, Representative DirectorMotoi Mitsuishi6127.06.202529.06.2023
Senior Managing Director, Senior Managing Executive Officer, Representative DirectorJunichi Sakaki6427.06.202528.06.2012
Managing Executive Officer, DirectorYutaka Kawakami65
Managing Executive Officer, DirectorKenji Miyajima5727.06.202529.06.2021
Managing Executive Officer, DirectorJunichi Nezu5804.08.2023
Managing Executive Officer, Chief Director of Pharmaceutical DevelopmentTaiji Hayano-27.06.202427.06.2019
Managing Executive Officer, Chief Director of Business Promotion, Manager of New Business OfficeYoshitaka Hosaka-01.04.202501.01.2019
Managing Executive Officer, Chief Director of Business DevelopmentTomokazu Matsusue-27.06.202428.06.2018
Managing Executive OfficerHitoshi Mizuno-27.06.202501.10.2018